@article{article, title  = {{Immunogenicity of SARSCoV2 Third Dose Vaccine Strategies in Immunocompromised Patients with Suboptimal Immunity Following Two Doses (OCTAVE-DUO): An Open-Label, Multi-Centre, Randomised, Controlled Phase III Trial}},

 url = {{}},

 year = {{-0001}},

 month = {{11}},

 author = {{Goodyear CS and Patel A and Barnes E and willicombe M and Siebert S and de Silva TI and Snowden JA and Lim S and Bowden S and Billingham LJ and Richter AG et al}},

 note = {{Accessed on 2024/12/20}}}